UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 75 filers reported holding UTAH MED PRODS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,170,000 | -3.5% | 13,200 | +2.3% | 0.00% | -20.0% |
| Q1 2020 | $1,213,000 | -10.8% | 12,900 | +2.4% | 0.01% | +25.0% |
| Q4 2019 | $1,360,000 | +14.5% | 12,600 | +1.6% | 0.00% | 0.0% |
| Q3 2019 | $1,188,000 | +1.7% | 12,400 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $1,168,000 | +12.2% | 12,200 | +3.4% | 0.00% | 0.0% |
| Q1 2019 | $1,041,000 | +42.4% | 11,800 | +34.1% | 0.00% | +33.3% |
| Q4 2018 | $731,000 | +6.2% | 8,800 | +20.5% | 0.00% | 0.0% |
| Q3 2018 | $688,000 | -14.4% | 7,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $804,000 | +11.4% | 7,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $722,000 | +23.2% | 7,300 | +1.4% | 0.00% | +50.0% |
| Q4 2017 | $586,000 | +3.5% | 7,200 | -6.5% | 0.00% | 0.0% |
| Q3 2017 | $566,000 | +70.0% | 7,700 | +67.4% | 0.00% | +100.0% |
| Q2 2017 | $333,000 | +61.7% | 4,600 | +39.4% | 0.00% | 0.0% |
| Q1 2017 | $206,000 | -14.2% | 3,300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $240,000 | +110.5% | 3,300 | +73.7% | 0.00% | 0.0% |
| Q3 2016 | $114,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penn Mutual Asset Management | 36,283 | $3,120,338 | 2.93% |
| Clean Yield Group | 31,263 | $2,684,554 | 1.19% |
| BARD ASSOCIATES INC | 18,181 | $1,563,566 | 0.65% |
| RICE HALL JAMES & ASSOCIATES, LLC | 111,634 | $9,600,524 | 0.61% |
| Ranger Investment Management | 74,411 | $6,399,346 | 0.42% |
| ISTHMUS PARTNERS, LLC | 21,307 | $1,832,402 | 0.26% |
| Cardinal Capital Management | 11,581 | $999,344 | 0.20% |
| Riverwater Partners LLC | 2,354 | $202,444 | 0.18% |
| GLOBEFLEX CAPITAL L P | 9,338 | $803,068 | 0.09% |
| JAMES INVESTMENT RESEARCH INC | 4,292 | $369,112 | 0.05% |